The Oncology Institute, Inc.
TOI
$2.96
-$0.14-4.52%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -7.51M | -16.50M | -17.01M | -19.59M | -13.18M |
| Total Depreciation and Amortization | 1.63M | 1.72M | 1.81M | 1.78M | 1.71M |
| Total Amortization of Deferred Charges | 1.21M | 1.17M | 1.13M | 4.87M | 1.59M |
| Total Other Non-Cash Items | 251.00K | 7.15M | 7.16M | 4.81M | 1.33M |
| Change in Net Operating Assets | 7.65M | -6.17M | -3.29M | 3.13M | 12.73M |
| Cash from Operations | 3.23M | -12.63M | -10.20M | -4.99M | 4.19M |
| Capital Expenditure | -1.06M | -604.00K | -1.21M | -328.00K | -1.76M |
| Sale of Property, Plant, and Equipment | 0.00 | 0.00 | 0.00 | 126.00K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 0.00 |
| Cash from Investing | -1.06M | -604.00K | -1.21M | -202.00K | -1.76M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -309.00K | -243.00K | -240.00K | -20.24M | -164.00K |
| Issuance of Common Stock | 4.09M | 10.84M | 2.20M | 15.50M | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -50.00K | -- | -- | -- | 0.00 |
| Cash from Financing | 3.73M | 10.60M | 1.96M | -4.74M | -164.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5.91M | -2.63M | -9.45M | -9.93M | 2.27M |